China Medical System Holdings Limited (0867.HK)
HKD 7.36
(-0.67%)
HKD 7.36
(-0.67%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 3.36 Billion CNY | -3.33% |
| 2022 | 3.39 Billion CNY | 11.86% |
| 2021 | 3.03 Billion CNY | 30.41% |
| 2020 | 2.32 Billion CNY | 8.44% |
| 2019 | 2.14 Billion CNY | 12.52% |
| 2018 | 1.9 Billion CNY | 20.72% |
| 2017 | 1.57 Billion CNY | 15.14% |
| 2016 | 1.37 Billion CNY | 40.13% |
| 2015 | 977.76 Million CNY | 30.77% |
| 2014 | 747.66 Million CNY | 29.51% |
| 2013 | 577.32 Million CNY | 24.43% |
| 2012 | 463.97 Million CNY | 26.63% |
| 2011 | 366.4 Million CNY | 28.42% |
| 2010 | 285.32 Million CNY | 21.91% |
| 2009 | 234.04 Million CNY | 23.17% |
| 2008 | 190.02 Million CNY | 7.42% |
| 2007 | 176.89 Million CNY | 11.13% |
| 2006 | 159.18 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 933.76 Million CNY | 14.59% |
| 2024 Q2 | 933.76 Million CNY | 0.0% |
| 2023 Q1 | 683.48 Million CNY | -28.63% |
| 2023 FY | 3.27 Billion CNY | -3.33% |
| 2023 Q4 | 814.87 Million CNY | -17.11% |
| 2023 Q3 | 983.02 Million CNY | 43.83% |
| 2023 Q2 | 683.48 Million CNY | 0.0% |
| 2022 Q1 | 707.03 Million CNY | -19.98% |
| 2022 FY | 3.39 Billion CNY | 11.86% |
| 2022 Q4 | 957.68 Million CNY | 0.0% |
| 2022 Q3 | 957.68 Million CNY | 35.45% |
| 2022 Q2 | 707.03 Million CNY | 0.0% |
| 2021 Q3 | 883.61 Million CNY | 64.13% |
| 2021 FY | 3.03 Billion CNY | 30.41% |
| 2021 Q1 | 538.34 Million CNY | -30.13% |
| 2021 Q4 | 883.61 Million CNY | 0.0% |
| 2021 Q2 | 538.34 Million CNY | 0.0% |
| 2020 Q3 | 770.48 Million CNY | 90.09% |
| 2020 FY | 2.32 Billion CNY | 8.44% |
| 2020 Q1 | 405.33 Million CNY | -28.7% |
| 2020 Q2 | 405.33 Million CNY | 0.0% |
| 2020 Q4 | 770.48 Million CNY | 0.0% |
| 2019 Q1 | 453.69 Million CNY | -15.07% |
| 2019 Q3 | 568.48 Million CNY | 25.3% |
| 2019 Q4 | 568.48 Million CNY | 0.0% |
| 2019 FY | 2.14 Billion CNY | 12.52% |
| 2019 Q2 | 453.69 Million CNY | 0.0% |
| 2018 Q2 | 398.13 Million CNY | 0.0% |
| 2018 Q4 | 534.2 Million CNY | 0.0% |
| 2018 FY | 1.9 Billion CNY | 20.72% |
| 2018 Q1 | 398.13 Million CNY | -4.09% |
| 2018 Q3 | 534.2 Million CNY | 34.18% |
| 2017 Q1 | 387.53 Million CNY | -7.2% |
| 2017 FY | 1.57 Billion CNY | 15.14% |
| 2017 Q4 | 415.1 Million CNY | 0.0% |
| 2017 Q3 | 415.1 Million CNY | 7.11% |
| 2017 Q2 | 387.53 Million CNY | 0.0% |
| 2016 FY | 1.37 Billion CNY | 40.13% |
| 2016 Q1 | 276.87 Million CNY | -0.69% |
| 2016 Q2 | 276.87 Million CNY | 0.0% |
| 2016 Q3 | 417.59 Million CNY | 50.83% |
| 2016 Q4 | 417.59 Million CNY | 0.0% |
| 2015 Q4 | 278.8 Million CNY | 0.0% |
| 2015 FY | 977.76 Million CNY | 30.77% |
| 2015 Q2 | 205.16 Million CNY | 0.0% |
| 2015 Q1 | 205.16 Million CNY | 70.53% |
| 2015 Q3 | 278.8 Million CNY | 35.89% |
| 2014 Q2 | 151.71 Million CNY | 0.0% |
| 2014 Q1 | 151.71 Million CNY | -14.88% |
| 2014 FY | 747.66 Million CNY | 29.51% |
| 2014 Q4 | 120.3 Million CNY | 0.0% |
| 2014 Q3 | 120.3 Million CNY | -20.7% |
| 2013 Q3 | 178.24 Million CNY | 71.42% |
| 2013 Q4 | 178.24 Million CNY | 0.0% |
| 2013 FY | 577.32 Million CNY | 24.43% |
| 2013 Q1 | 103.98 Million CNY | -23.43% |
| 2013 Q2 | 103.98 Million CNY | 0.0% |
| 2012 FY | 463.97 Million CNY | 26.63% |
| 2012 Q2 | - CNY | 100.0% |
| 2012 Q1 | -119.74 Million CNY | 0.0% |
| 2012 Q3 | 136.98 Million CNY | 0.0% |
| 2012 Q4 | 135.8 Million CNY | -0.86% |
| 2011 Q2 | - CNY | 0.0% |
| 2011 FY | 366.4 Million CNY | 28.42% |
| 2011 Q4 | - CNY | 0.0% |
| 2010 FY | 285.32 Million CNY | 21.91% |
| 2010 Q4 | - CNY | 0.0% |
| 2010 Q2 | - CNY | 0.0% |
| 2009 FY | 234.04 Million CNY | 23.17% |
| 2008 FY | 190.02 Million CNY | 7.42% |
| 2007 FY | 176.89 Million CNY | 11.13% |
| 2006 FY | 159.18 Million CNY | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 24.42 Million HKD | -13669.665% |
| Grand Pharmaceutical Group Limited | 3.86 Billion HKD | 12.888% |
| Extrawell Pharmaceutical Holdings Limited | 35.52 Million HKD | -9366.33% |
| Wai Yuen Tong Medicine Holdings Limited | 353.93 Million HKD | -850.209% |
| Qianhai Health Holdings Limited | 17.1 Million HKD | -19564.969% |
| Lee's Pharmaceutical Holdings Limited | 590.99 Million HKD | -469.061% |
| Essex Bio-Technology Limited | 1.22 Billion HKD | -173.654% |
| Tongfang Kontafarma Holdings Limited | 503.46 Million HKD | -567.994% |
| PuraPharm Corporation Limited | 216.62 Million HKD | -1452.471% |
| SSY Group Limited | 1.98 Billion HKD | -69.79% |
| JBM (Healthcare) Limited | 163.87 Million HKD | -1952.224% |
| Jacobson Pharma Corporation Limited | 287.34 Million HKD | -1070.39% |
| China Resources Pharmaceutical Group Limited | 29.35 Billion HKD | 88.543% |